可乐定治疗原发性顽固性高血压的疗效观察

徐云根; 张宁; 何义; 徐云根; 张宁; 何义

doi:10.3969/j.issn.1006-0111.2013.03.014

[1]

Calhoun DA, Jones D, Textor S, et al. Resistant hypertension:diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research[J]. Hypertension, 2008, 51:1403.

[2]

White WB, Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy[J].Am J Cardial, 1989, 63:94.

[3]

Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertention (The Symplicity HTN-2 Trial):a randomized controlled trial[J]. Lancet, 2010, 376(9756):1903.

[4]

Scheffers IJ, Kroon AA, Schmidli J, et al. Novel baroreflex antivation theraphy in resistant hypertension:results of European multi-center feasibility study[J]. J Am coll cardiol, 2010, 56(15):1254.

[5]

中国药典.二部[S]. 附录,2005:181.

[6]

陈文生,史月生,王伟忠,等.尾端延髓腹外侧区咪唑啉受体在可乐定中枢降压中的作用[J]. 第二军医大学学报,2004,25(8):835.